Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research 06 Biological Sciences 0601 Biochemistry and Cell Biology 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

Kiyoung Eun, Min Gi Park, Yeon Woo Jeong, Yeon Ik Jeong, Sang Hwan Hyun, Woo Suk Hwang, Sung Hak Kim, Hyunggee Kim

Research output: Contribution to journalArticle

Abstract

Background: Genetic engineering technology such as clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system provides a powerful tool for developing disease models and determining gene functions. Recent interests in canine cancer models have highlighted the necessity of developing genetic engineering tools for dogs. In this study, we attempted to generate optimized CRISPR/Cas9 system to target canine tumor protein 53 (TP53), one of the most crucial tumor suppressor genes, to establish TP53 knockout canine cells for canine cancer research. Results: We constructed CRISPR/Cas9 vectors using each of three TP53 gene-targeting guide RNAs (gRNAs) with minimal off-target potential. After transfection, we obtained several clones of TP53 knockout cells containing "indel" mutations in the targeted locus which had infinite cellular life span, resistance to genotoxicity, and unstable genomic status in contrast to normal cells. Of the established TP53 knockout cells, TP53KO#30 cells targeted by TP53 gRNA #30 showed non-cancerous phenotypes without oncogenic activation both in vitro and in vivo. More importantly, no off-target alteration was detected in TP53KO#30 cells. We also tested the developmental capacity of TP53 knockout cells after application of the somatic cell nuclear transfer technique. Conclusions: Our results indicated that TP53 in canine cells was effectively and specifically targeted by our CRISPR/Cas9 system. Thus, we suggest our CRISPR/Cas9-derived canine TP53 knockout cells as a useful platform to reveal novel oncogenic functions and effects of developing anti-cancer therapeutics.

Original languageEnglish
Article number19
JournalBMC Biotechnology
Volume19
Issue number1
DOIs
Publication statusPublished - 2019 Jan 3

Fingerprint

Biological Science Disciplines
Biochemistry
Cell Biology
Canidae
Carcinogenesis
Clustered Regularly Interspaced Short Palindromic Repeats
Health
Research
Neoplasms
Proteins
Guide RNA
Genetic Engineering
Nuclear Transfer Techniques
Gene Targeting
Tumor Suppressor Genes
Transfection
Clone Cells
Dogs

Keywords

  • Cancer
  • CRISPR/Cas9
  • Dog
  • Knockout
  • TP53

ASJC Scopus subject areas

  • Biotechnology

Cite this

Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research 06 Biological Sciences 0601 Biochemistry and Cell Biology 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. / Eun, Kiyoung; Park, Min Gi; Jeong, Yeon Woo; Jeong, Yeon Ik; Hyun, Sang Hwan; Hwang, Woo Suk; Kim, Sung Hak; Kim, Hyunggee.

In: BMC Biotechnology, Vol. 19, No. 1, 19, 03.01.2019.

Research output: Contribution to journalArticle

@article{52528836070045378ab7e9e509656fca,
title = "Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research 06 Biological Sciences 0601 Biochemistry and Cell Biology 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis",
abstract = "Background: Genetic engineering technology such as clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system provides a powerful tool for developing disease models and determining gene functions. Recent interests in canine cancer models have highlighted the necessity of developing genetic engineering tools for dogs. In this study, we attempted to generate optimized CRISPR/Cas9 system to target canine tumor protein 53 (TP53), one of the most crucial tumor suppressor genes, to establish TP53 knockout canine cells for canine cancer research. Results: We constructed CRISPR/Cas9 vectors using each of three TP53 gene-targeting guide RNAs (gRNAs) with minimal off-target potential. After transfection, we obtained several clones of TP53 knockout cells containing {"}indel{"} mutations in the targeted locus which had infinite cellular life span, resistance to genotoxicity, and unstable genomic status in contrast to normal cells. Of the established TP53 knockout cells, TP53KO#30 cells targeted by TP53 gRNA #30 showed non-cancerous phenotypes without oncogenic activation both in vitro and in vivo. More importantly, no off-target alteration was detected in TP53KO#30 cells. We also tested the developmental capacity of TP53 knockout cells after application of the somatic cell nuclear transfer technique. Conclusions: Our results indicated that TP53 in canine cells was effectively and specifically targeted by our CRISPR/Cas9 system. Thus, we suggest our CRISPR/Cas9-derived canine TP53 knockout cells as a useful platform to reveal novel oncogenic functions and effects of developing anti-cancer therapeutics.",
keywords = "Cancer, CRISPR/Cas9, Dog, Knockout, TP53",
author = "Kiyoung Eun and Park, {Min Gi} and Jeong, {Yeon Woo} and Jeong, {Yeon Ik} and Hyun, {Sang Hwan} and Hwang, {Woo Suk} and Kim, {Sung Hak} and Hyunggee Kim",
year = "2019",
month = "1",
day = "3",
doi = "10.1186/s12896-018-0491-5",
language = "English",
volume = "19",
journal = "BMC Biotechnology",
issn = "1472-6750",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research 06 Biological Sciences 0601 Biochemistry and Cell Biology 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

AU - Eun, Kiyoung

AU - Park, Min Gi

AU - Jeong, Yeon Woo

AU - Jeong, Yeon Ik

AU - Hyun, Sang Hwan

AU - Hwang, Woo Suk

AU - Kim, Sung Hak

AU - Kim, Hyunggee

PY - 2019/1/3

Y1 - 2019/1/3

N2 - Background: Genetic engineering technology such as clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system provides a powerful tool for developing disease models and determining gene functions. Recent interests in canine cancer models have highlighted the necessity of developing genetic engineering tools for dogs. In this study, we attempted to generate optimized CRISPR/Cas9 system to target canine tumor protein 53 (TP53), one of the most crucial tumor suppressor genes, to establish TP53 knockout canine cells for canine cancer research. Results: We constructed CRISPR/Cas9 vectors using each of three TP53 gene-targeting guide RNAs (gRNAs) with minimal off-target potential. After transfection, we obtained several clones of TP53 knockout cells containing "indel" mutations in the targeted locus which had infinite cellular life span, resistance to genotoxicity, and unstable genomic status in contrast to normal cells. Of the established TP53 knockout cells, TP53KO#30 cells targeted by TP53 gRNA #30 showed non-cancerous phenotypes without oncogenic activation both in vitro and in vivo. More importantly, no off-target alteration was detected in TP53KO#30 cells. We also tested the developmental capacity of TP53 knockout cells after application of the somatic cell nuclear transfer technique. Conclusions: Our results indicated that TP53 in canine cells was effectively and specifically targeted by our CRISPR/Cas9 system. Thus, we suggest our CRISPR/Cas9-derived canine TP53 knockout cells as a useful platform to reveal novel oncogenic functions and effects of developing anti-cancer therapeutics.

AB - Background: Genetic engineering technology such as clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system provides a powerful tool for developing disease models and determining gene functions. Recent interests in canine cancer models have highlighted the necessity of developing genetic engineering tools for dogs. In this study, we attempted to generate optimized CRISPR/Cas9 system to target canine tumor protein 53 (TP53), one of the most crucial tumor suppressor genes, to establish TP53 knockout canine cells for canine cancer research. Results: We constructed CRISPR/Cas9 vectors using each of three TP53 gene-targeting guide RNAs (gRNAs) with minimal off-target potential. After transfection, we obtained several clones of TP53 knockout cells containing "indel" mutations in the targeted locus which had infinite cellular life span, resistance to genotoxicity, and unstable genomic status in contrast to normal cells. Of the established TP53 knockout cells, TP53KO#30 cells targeted by TP53 gRNA #30 showed non-cancerous phenotypes without oncogenic activation both in vitro and in vivo. More importantly, no off-target alteration was detected in TP53KO#30 cells. We also tested the developmental capacity of TP53 knockout cells after application of the somatic cell nuclear transfer technique. Conclusions: Our results indicated that TP53 in canine cells was effectively and specifically targeted by our CRISPR/Cas9 system. Thus, we suggest our CRISPR/Cas9-derived canine TP53 knockout cells as a useful platform to reveal novel oncogenic functions and effects of developing anti-cancer therapeutics.

KW - Cancer

KW - CRISPR/Cas9

KW - Dog

KW - Knockout

KW - TP53

UR - http://www.scopus.com/inward/record.url?scp=85059501453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059501453&partnerID=8YFLogxK

U2 - 10.1186/s12896-018-0491-5

DO - 10.1186/s12896-018-0491-5

M3 - Article

C2 - 30606176

AN - SCOPUS:85059501453

VL - 19

JO - BMC Biotechnology

JF - BMC Biotechnology

SN - 1472-6750

IS - 1

M1 - 19

ER -